Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis. [PDF]
Biegelmeyer E +48 more
europepmc +1 more source
Evaluation of Reactogenicity and Neutralizing Antibody Responses 6 Months Post-Vaccination with Monovalent COVID-19 Vaccine. [PDF]
Lim SY +12 more
europepmc +1 more source
Vaccine Platform-Dependent Differential Impact on Microbiome Diversity: Potential Advantages of Protein Subunit Vaccines. [PDF]
Seong H +8 more
europepmc +1 more source
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222). [PDF]
Belij-Rammerstorfer S +26 more
europepmc +1 more source
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study. [PDF]
Chemaitelly H +21 more
europepmc +1 more source
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial. [PDF]
Rumyantsev A +25 more
europepmc +1 more source
Kinetics of cellular immune response to SARS-CoV-2 vaccine boosters in dialysis and kidney transplant patients without infection. [PDF]
Souza RM +5 more
europepmc +1 more source
Identification of novel genetic biomarkers for ChAdOx1 nCoV-19 mediated immunogenicity. [PDF]
Chou WH +21 more
europepmc +1 more source
Evaluation of the Humoral Immune Response Following Two Doses of a Coronavirus Disease 2019 Vector-Based Vaccine During the Initial Rollout in Bangladesh. [PDF]
Sultana S +5 more
europepmc +1 more source
SARS-CoV-2 vaccines elicit differential Fc effector functions. [PDF]
Manamela NP +12 more
europepmc +1 more source

